NS
Article DetailSEC EDGAR Filings
SEC EDGAR Filings

8-K - IMMUNIC, INC. - 3.03 / 5.03 / 8.01 / 9.01

Filed: 2026-04-23 AccNo: 0001193805-26-000495 Size: 223 KB Item 3.03: Material Modifications to Rights of Security Holders Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year Item 8.01: Other Events Item 9.01: Financial Statements and Exhibits
发布时间04/23 12:30 UTC
首次发现04/23 12:35 UTC
热度104.6
重要度58
情绪0.00

站内整理正文

优先显示结构化正文;如果正文还未抽出,则回退到摘要。
sec_edgar_index_v1 · 821 字符

Form 8-K - Current report: SEC Accession No. 0001193805-26-000495

Filing Date: 2026-04-23

Accepted: 2026-04-23 08:30:43

Documents: 14

Period of Report: 2026-04-22

Items: Item 3.03: Material Modifications to Rights of Security Holders Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year Item 8.01: Other Events Item 9.01: Financial Statements and Exhibits

IMMUNIC, INC. (Filer) CIK : 0001280776 (see all company filings) EIN. : 562358443 | State of Incorp.: DE | Fiscal Year End: 1231 Type: 8-K | Act: 34 | File No.: 001-36201 | Film No.: 26885710 SIC : 2834 Pharmaceutical Preparations (CF Office: 03 Life Sciences)

1 | e665386_8k-immunic.htm iXBRL | 8-K | 25555

2 | e665386_ex3-1.htm | EX-3.1 | 5858

3 | e665386_ex99-1.htm | EX-99.1 | 14101

7 | GRAPHIC | image_001.jpg | GRAPHIC